2020

Correspondence: Dr W Chan, Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong. Email: cw698@ha.org.hk

 

Submitted: 14 Feb 2019; Accepted: 29 Jul 2019.

 

Contributors: All authors contributed to the concept of study, acquisition and analysis of data, drafting of the manuscript, and had critical revision of the manuscript for important intellectual content. All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.

 

Conflicts of Interest: As an editor of the journal, FCS Wong was not involved in the peer review process. Other authors have disclosed no conflicts of interest.

 

Funding/Support: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

 

Ethics Approval: This retrospective study was approved by the New Territories West Research Ethics Committee (Ref NTWC/CREC/18053).

 

 

 

Correspondence: Dr L Fok, Department of Clinical Oncology, Queen Elizabeth Hospital, Jordan, Hong Kong. Email: leslie.fok@link.cuhk.edu.hk

 

Submitted: 7 Jun 2019; Accepted: 3 Sep 2019.

 

Contributors: LF and KMC designed the study and acquired the data. All authors contributed to the analysis of data, drafted the manuscript, and had critical revision of the manuscript for important intellectual content. All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.

 

Conflicts of Interest: The authors have no conflicts of interest to disclose.

 

Funding/Support: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

 

Ethics Approval: This study was approved by the Research Ethics Committee (Kowloon Central/Kowloon East) of the Hospital Authority, Hong Kong (Ref KC/KE-19-0046-ER/4). The requirement for patient consent was waived. All patients were treated in compliance with the Declaration of Helsinki.

 

 

 

Correspondence: Dr WK Ho, Department of Clinical Oncology, Queen Elizabeth Hospital, Jordan, Hong Kong. Email: hwk757@ha.org.hk

 

Submitted: 12 Feb 2018; Accepted: 2 Oct 2018.

 

Contributors: WKH and RKCN designed the study. WKH, CWYY, FKHL and JCFL acquired the data. WKH and RKCN analysed the data, drafted the manuscript, and had critical revision of the manuscript for important intellectual content. All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.

 

Conflicts of Interest: As an editor of the journal, RKC Ngan was not involved in the peer review process. Other authors have disclosed no conflicts of interest.

 

Funding/Support: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

 

Ethics Approval: This study has been approved by the Research Ethics Committee of the Hospital Authority (Ref KC/KE-18-0002/ER-2). The requirement for patient consent was waived by the Research Ethics Committee.